| Company name | Balchem Corporation |
| Stock ticker | BCPC |
| Live stock price | [stckqut]BCPC[/stckqut] |
| P/E compared to competitors | Fair |
MANAGEMENT EXECUTION
| Employee productivity | Good |
| Sales growth | Good |
| EPS growth | Good |
| P/E growth | Good |
| EBIT growth | Good |
ANALYSIS
| Confident Investor Rating | Good |
| Target stock price (TWCA growth scenario) | $47.17 |
| Target stock price (averages with growth) | $54.66 |
| Target stock price (averages with no growth) | $39.44 |
| Target stock price (manual assumptions) | $45.46 |
The following company description is from Google Finance: http://www.google.com/finance?q=bcpc
Balchem Corporation (Balchem) is engaged in the development, manufacture and marketing of specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical and medical sterilization industries. The Company has three reportable segments: Specialty Products, Food, Pharma & Nutrition, and Animal Nutrition & Health. The Company sells its products through its own sales force, independent distributors and sales agents. The Company operates five wholly owned domestic subsidiaries, such as BCP Ingredients, Inc., Aberco, Inc., Balchem BV, Balchem Trading BV and Balchem Italia Srl. The Food, Pharma & Nutrition (FPN) segment provides microencapsulation solutions to a variety of applications in food, pharmaceutical and nutritional ingredients to enhance performance of nutritional fortification, processing, mixing, and packaging applications and shelf-life. Balchem’s Specialty Products segment operates in industry as ARC Specialty Products.
Confident Investor comments: At this price and at this time, I think that a Confident Investor can confidently invest in this stock.